Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03780244 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Sculptra Aesthetic for Correction of Nasolabial Folds.
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03780244 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 80 participants.
The verdict
NCT03780244, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study has been designed to evaluate the safety of Sculptra Aesthetic as a single regimen for correction of Nasolabial Fold (NLF) contour deficiencies after changes in reconstitution and injection procedures compared to the approved label.
Interventions
- DEVICE Sculptra Aesthetic 8ml
- DEVICE Sculptra Aesthetic 5ml
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2020-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03780244
The ClinicalTrials.gov registry entry for NCT03780244 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sculptra Aesthetic 8ml is the first listed.
NCT03780244 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03780244 about?
NCT03780244 is a clinical study titled "Safety and Effectiveness of Sculptra Aesthetic for Correction of Nasolabial Folds.". This study has been designed to evaluate the safety of Sculptra Aesthetic as a single regimen for correction of Nasolabial Fold (NLF) contour deficiencies after changes in reconstitution and injection procedures compared to the approved label.
What is the current status of trial NCT03780244?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2018-12-18. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03780244?
The interventions under investigation include: Sculptra Aesthetic 8ml (DEVICE), Sculptra Aesthetic 5ml (DEVICE).
Who is sponsoring clinical trial NCT03780244?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.